Posts

Showing posts with the label Type 1 diabetes treatment Dual-action diabetes therapy Inflammation and Type 1 diabetes Beta cell preservation

A dual-action therapy targeting inflammation and beta cells may transform Type 1 diabetes care, offering a disease-modifying breakthrough.